In the company's second-quarter results call, Lilly's chief scientific officer Daniel Skovronsky revealed that orally active anti-tau drug LY3372689 – an O-GlcNAcase (OGA) inhibitor – failed a ...

Phase 2 trials, meanwhile, are underway in hidradenitis suppurativa (HS), systemic sclerosis, coeliac disease, and alopecia. Sanofi also said today that it is expanding the development of asthma ...

UEFA Conference League 2025/2026 qualif. 2 draw schedule confirmed. Find out who is facing who in UEFA Conference League 2025/2026 qualif. 2.

This variant provides 2 audio outputs but no audio inputs or CV ports. Plugin type is set as "instrument". FX. This variant provides 2 audio inputs and outputs, but no CV ports. Plugin type is set as ...